missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. BTLA/CD272 Mouse anti-Human, Clone: BTLA/1528, Novus Biologicals™

BTLA/CD272 Mouse anti-Human, Clone: BTLA/1528, Novus Biologicals™

Mouse Monoclonal Antibody

£377.00

Specifications

Antigen BTLA/CD272
Clone BTLA/1528
Concentration 0.2 mg/mL
Dilution ELISA
Applications Flow Cytometry, ELISA
View More Specs

Products 1
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
18696977
View Documents
missing translation for 'viewProductCertificates'
Novus Biologicals
NBP3-07803-100ug 		100 μg
£377.00
100µg
View alternative products
Save Up to  »
Please to purchase this item. Need a web account? Register with us today!
Description

Description

BTLA/CD272 Monoclonal specifically detects BTLA/CD272 in Human samples. It is validated for ELISA.
Specifications

Specifications

BTLA/CD272
0.2 mg/mL
Flow Cytometry, ELISA
Unconjugated
Mouse
Cell Cycle and Replication, Phospho Specific
10 mM PBS with 0.05% BSA
151888
IgG1 κ
Protein A or G purified
BTLA/1528
ELISA
Monoclonal
Purified
RUO
Human
B and T lymphocyte associated, B and T lymphocyte attenuator, B- and T-lymphocyte attenuator, B- and T-lymphocyte-associated protein, BTLA1, CD272, CD272 antigen, FLJ16065, MGC129743
Recombinant full-length human BTLA/CD272 protein
Primary
Store at 4°C.
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.